title: Interventional treatment of acute hepatic artery occlusion after liver transplantation.
abstract: BACKGROUND
  With the development of the associated technology, interventional treatment has become an important method for the treatment of hepatic artery occlusion in some countries. This study was undertaken to evaluate the role of interventional methods in the diagnosis and treatment of acute hepatic artery occlusion after liver transplantation.
  
  
  METHODS
  The diagnosis and treatment of 9 cases of acute hepatic artery occlusion after liver transplantation were retrospectively analyzed.
  
  
  RESULTS
  In 109 cases of liver transplantation, 9 were diagnosed by angiography. Among them, 7 were diagnosed by Doppler ultrasound. After transcatheter thrombolysis, the hepatic arteries were partially or totally patent again in 6 cases of hepatic artery occlusion after liver transplantation, and stent placements in the hepatic artery were performed in 5 cases. All stents proved patent and no patient required another liver transplantation.
  
  
  CONCLUSIONS
  Angiography plays an important role in diagnosing hepatic artery complications after liver transplantation. Interventional therapy is a valuable method in the treatment of acute hepatic artery occlusion after liver transplantation.
authors: Department of General Surgery, Dongguan Kanghua Hospital, Dongguan 523080, China. lizhiwei67@126.com
authors: Zhi-Wei
authors: ZW
authors: Li
authors: Mao-Qiang
authors: MQ
authors: Wang
authors: Ning-Xin
authors: NX
authors: Zhou
authors: Zhe
authors: Z
authors: Liu
authors: Zhi-Qiang
authors: ZQ
authors: Huang
mesh_terms: D000328:Adult; D000792:Angiography; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000628:therapy*; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D015607:Stents; D015912:Thrombolytic Therapy / Q000379:methods*; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator